Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Identification of a Novel Simian Immunodeficiency Virus-Infected African Green Monkey (Chlorocebus tantalus) Confirms that Tantalus Monkeys in Cameroon Are Infected with a Mosaic SIVagm Lineage.

Augier C, Beyne E, Villabona-Arenas CJ, Mpoudi Ngole E, Peeters M, Ayouba A.

AIDS Res Hum Retroviruses. 2019 Oct 30. doi: 10.1089/AID.2019.0216. [Epub ahead of print]

PMID:
31547667
2.

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon.

Tchouwa GF, Eymard-Duvernay S, Cournil A, Lamare N, Serrano L, Butel C, Bertagnolio S, Mpoudi-Ngole E, Raizes E, Aghokeng AF; EHRICA Study Group.

EClinicalMedicine. 2018 Jul 4;1:21-27. doi: 10.1016/j.eclinm.2018.06.005. eCollection 2018 Jul.

3.

Understanding Ebola virus and other zoonotic transmission risks through human-bat contacts: Exploratory study on knowledge, attitudes and practices in Southern Cameroon.

Baudel H, De Nys H, Mpoudi Ngole E, Peeters M, Desclaux A.

Zoonoses Public Health. 2019 May;66(3):288-295. doi: 10.1111/zph.12563. Epub 2019 Jan 24.

PMID:
30677236
4.

Extensive Serological Survey of Multiple African Nonhuman Primate Species Reveals Low Prevalence of Immunoglobulin G Antibodies to 4 Ebola Virus Species.

Ayouba A, Ahuka-Mundeke S, Butel C, Mbala Kingebeni P, Loul S, Tagg N, Villabona-Arenas CJ, Lacroix A, Ndimbo-Kumugo SP, Keita AK, Toure A, Couacy-Hymann E, Calvignac-Spencer S, Leendertz FH, Formenty P, Delaporte E, Muyembe-Tamfum JJ, Mpoudi Ngole E, Peeters M.

J Infect Dis. 2019 Oct 8;220(10):1599-1608. doi: 10.1093/infdis/jiz006.

PMID:
30657940
5.

Noninvasive western lowland gorilla's health monitoring: A decade of simian immunodeficiency virus surveillance in southern Cameroon.

Villabona-Arenas CJ, Ayouba A, Esteban A, D'arc M, Mpoudi Ngole E, Peeters M.

Ecol Evol. 2018 Oct 25;8(22):10698-10710. doi: 10.1002/ece3.4478. eCollection 2018 Nov.

6.

Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM).

Liégeois F, Eymard-Duvernay S, Boyer S, Maradan G, Kouanfack C, Domyeum J, Boyer V, Mpoudi-Ngolé E, Spire B, Delaporte E, Vidal L, Kuaban C, Laurent C; EVOLCAM study group.

HIV Med. 2019 Jan;20(1):38-46. doi: 10.1111/hiv.12681. Epub 2018 Oct 25.

PMID:
30362279
7.

Survey of Ebola Viruses in Frugivorous and Insectivorous Bats in Guinea, Cameroon, and the Democratic Republic of the Congo, 2015-2017.

De Nys HM, Kingebeni PM, Keita AK, Butel C, Thaurignac G, Villabona-Arenas CJ, Lemarcis T, Geraerts M, Vidal N, Esteban A, Bourgarel M, Roger F, Leendertz F, Diallo R, Ndimbo-Kumugo SP, Nsio-Mbeta J, Tagg N, Koivogui L, Toure A, Delaporte E, Ahuka-Mundeke S, Tamfum JM, Mpoudi-Ngole E, Ayouba A, Peeters M.

Emerg Infect Dis. 2018 Dec;24(12):2228-2240. doi: 10.3201/eid2412.180740. Epub 2018 Dec 17.

8.

Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey.

Tchouwa GF, Eymard-Duvernay S, Cournil A, Lamare N, Serrano L, Butel C, Bertagnolio S, Mpoudi-Ngole E, Raizes E, Aghokeng AF; Members of the EHRICA Study Group.

J Antimicrob Chemother. 2018 Sep 1;73(9):2468-2474. doi: 10.1093/jac/dky221.

PMID:
29931063
9.

Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets.

Boullé C, Guichet E, Kouanfack C, Aghokeng A, Onambany B, Ikaka CM, Ngock E, Tsoumsta L, Msellati P, Mpoudi-Ngolé E, Peeters M, Delaporte E, Laurent C.

Open Forum Infect Dis. 2016 Dec 20;3(4):ofw233. doi: 10.1093/ofid/ofw233. eCollection 2016 Oct.

10.

Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon.

Guichet E, Aghokeng A, Eymard-Duvernay S, Vidal N, Ayouba A, Mpoudi Ngole E, Delaporte E, Ciaffi L, Peeters M.

J Virol Methods. 2016 Nov;237:121-126. doi: 10.1016/j.jviromet.2016.09.005. Epub 2016 Sep 5.

11.

HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges.

Villabona-Arenas CJ, Domyeum J, Mouacha F, Butel C, Delaporte E, Peeters M, Mpoudi-Ngole E, Aghokeng AF.

Infect Genet Evol. 2015 Dec;36:210-216. doi: 10.1016/j.meegid.2015.09.006. Epub 2015 Sep 11.

12.

Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country.

Tongo M, Dorfman JR, Abrahams MR, Mpoudi-Ngole E, Burgers WA, Martin DP.

Evol Med Public Health. 2015 Sep 9;2015(1):254-65. doi: 10.1093/emph/eov022.

13.

Phylogenetics of HIV-1 subtype G env: Greater complexity and older origins than previously reported.

Tongo M, Essomba RG, Nindo F, Abrahams F, Nanfack AJ, Fokam J, Takou D, Torimiro JN, Mpoudi-Ngole E, Burgers WA, Martin DP, Dorfman JR.

Infect Genet Evol. 2015 Oct;35:9-18. doi: 10.1016/j.meegid.2015.07.017. Epub 2015 Jul 17.

PMID:
26190450
14.

Origin of the HIV-1 group O epidemic in western lowland gorillas.

D'arc M, Ayouba A, Esteban A, Learn GH, Boué V, Liegeois F, Etienne L, Tagg N, Leendertz FH, Boesch C, Madinda NF, Robbins MM, Gray M, Cournil A, Ooms M, Letko M, Simon VA, Sharp PM, Hahn BH, Delaporte E, Mpoudi Ngole E, Peeters M.

Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1343-52. doi: 10.1073/pnas.1502022112. Epub 2015 Mar 2.

15.

Evaluating potential T-cell epitope peptides for detecting HIV-specific T cell responses in a highly diverse HIV-1 epidemic from Cameroon.

Tongo M, Riou C, Crunchant E, Müller TL, Strickland N, Mpoudi-Ngole E, Burgers WA.

AIDS. 2015 Mar 13;29(5):635-639. doi: 10.1097/QAD.0000000000000581.

16.

Rapid changes in the gut microbiome during human evolution.

Moeller AH, Li Y, Mpoudi Ngole E, Ahuka-Mundeke S, Lonsdorf EV, Pusey AE, Peeters M, Hahn BH, Ochman H.

Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16431-5. doi: 10.1073/pnas.1419136111. Epub 2014 Nov 3.

17.

Characterization of Enteroviruses from non-human primates in cameroon revealed virus types widespread in humans along with candidate new types and species.

Sadeuh-Mba SA, Bessaud M, Joffret ML, Endegue Zanga MC, Balanant J, Mpoudi Ngole E, Njouom R, Reynes JM, Delpeyroux F, Rousset D.

PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3052. doi: 10.1371/journal.pntd.0003052. eCollection 2014.

18.

HIV infection and risk factors among the armed forces personnel stationed in Kinshasa, Democratic Republic of Congo.

Rimoin AW, Hoff NA, Djoko CF, Kisalu NK, Kashamuka M, Tamoufe U, LeBreton M, Kayembe PK, Muyembe JJ, Kitchen CR, Saylors K, Fair J, Doshi R, Papworth E, Mpoudi-Ngole E, Grillo MP, Tshala F, Peeters M, Wolfe ND.

Int J STD AIDS. 2015 Mar;26(3):187-95. doi: 10.1177/0956462414533672. Epub 2014 May 14.

PMID:
24828556
19.

Assessment of gastrointestinal parasites in wild chimpanzees (Pan troglodytes troglodytes) in southeast Cameroon.

Drakulovski P, Bertout S, Locatelli S, Butel C, Pion S, Mpoudi-Ngole E, Delaporte E, Peeters M, Mallié M.

Parasitol Res. 2014 Jul;113(7):2541-50. doi: 10.1007/s00436-014-3904-y. Epub 2014 Apr 30.

20.

Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa.

Taieb F, Aghokeng AF, Eymard-Duvernay S, Chia JE, Einterz E, Mpoudi-Ngole E, Peeters M, Molina JM, Delaporte E.

AIDS Res Hum Retroviruses. 2014 Jul;30(7):623-5. doi: 10.1089/AID.2014.0035. Epub 2014 Apr 14. No abstract available.

PMID:
24645979
21.

Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: implications for vaccine development.

Tongo M, Zembe L, Ebong E, Roux S, Bekker LG, Williamson C, Mpoudi-Ngole E, Burgers WA.

Vaccine. 2014 Apr 25;32(20):2328-36. doi: 10.1016/j.vaccine.2014.02.063. Epub 2014 Mar 2.

PMID:
24598726
22.

African origin of the malaria parasite Plasmodium vivax.

Liu W, Li Y, Shaw KS, Learn GH, Plenderleith LJ, Malenke JA, Sundararaman SA, Ramirez MA, Crystal PA, Smith AG, Bibollet-Ruche F, Ayouba A, Locatelli S, Esteban A, Mouacha F, Guichet E, Butel C, Ahuka-Mundeke S, Inogwabini BI, Ndjango JB, Speede S, Sanz CM, Morgan DB, Gonder MK, Kranzusch PJ, Walsh PD, Georgiev AV, Muller MN, Piel AK, Stewart FA, Wilson ML, Pusey AE, Cui L, Wang Z, Färnert A, Sutherland CJ, Nolder D, Hart JA, Hart TB, Bertolani P, Gillis A, LeBreton M, Tafon B, Kiyang J, Djoko CF, Schneider BS, Wolfe ND, Mpoudi-Ngole E, Delaporte E, Carter R, Culleton RL, Shaw GM, Rayner JC, Peeters M, Hahn BH, Sharp PM.

Nat Commun. 2014;5:3346. doi: 10.1038/ncomms4346.

23.

Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the Stratall ANRS 12110/ESTHER trial in Cameroon.

Boullé C, Kouanfack C, Laborde-Balen G, Aghokeng AF, Boyer S, Carrieri MP, Kazé S, Mben JM, Dontsop M, Spire B, Peeters M, Mpoudi-Ngolé E, Delaporte E, Laurent C; Stratall ANRS 12110/ESTHER Study Group.

Clin Infect Dis. 2013 Aug;57(4):604-7. doi: 10.1093/cid/cit323. Epub 2013 May 10.

PMID:
23667264
24.

Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.

Boyer S, March L, Kouanfack C, Laborde-Balen G, Marino P, Aghokeng AF, Mpoudi-Ngole E, Koulla-Shiro S, Delaporte E, Carrieri MP, Spire B, Laurent C, Moatti JP; Stratall ANRS 12110/ESTHER Study Group.

Lancet Infect Dis. 2013 Jul;13(7):577-86. doi: 10.1016/S1473-3099(13)70073-2. Epub 2013 Apr 18.

PMID:
23602084
25.

Plasmodium falciparum-like parasites infecting wild apes in southern Cameroon do not represent a recurrent source of human malaria.

Sundararaman SA, Liu W, Keele BF, Learn GH, Bittinger K, Mouacha F, Ahuka-Mundeke S, Manske M, Sherrill-Mix S, Li Y, Malenke JA, Delaporte E, Laurent C, Mpoudi Ngole E, Kwiatkowski DP, Shaw GM, Rayner JC, Peeters M, Sharp PM, Bushman FD, Hahn BH.

Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):7020-5. doi: 10.1073/pnas.1305201110. Epub 2013 Apr 8.

26.

Molecular evidence for the presence of Rickettsia Felis in the feces of wild-living African apes.

Keita AK, Socolovschi C, Ahuka-Mundeke S, Ratmanov P, Butel C, Ayouba A, Inogwabini BI, Muyembe-Tamfum JJ, Mpoudi-Ngole E, Delaporte E, Peeters M, Fenollar F, Raoult D.

PLoS One. 2013;8(2):e54679. doi: 10.1371/journal.pone.0054679. Epub 2013 Feb 6.

27.

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon.

Aghokeng AF, Kouanfack C, Eymard-Duvernay S, Butel C, Edoul GE, Laurent C, Koulla-Shiro S, Delaporte E, Mpoudi-Ngole E, Peeters M.

J Int AIDS Soc. 2013 Jan 31;16:18004. doi: 10.7448/IAS.16.1.18004.

28.

Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic.

Tongo M, Martin DP, Zembe L, Mpoudi-Ngole E, Williamson C, Burgers WA.

Virol J. 2013 Jan 22;10:29. doi: 10.1186/1743-422X-10-29.

29.

Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.

Gabillard D, Lewden C, Ndoye I, Moh R, Segeral O, Tonwe-Gold B, Etard JF, Pagnaroat M, Fournier-Nicolle I, Eholié S, Konate I, Minga A, Mpoudi-Ngole E, Koulla-Shiro S, Zannou DM, Anglaret X, Laurent C; ANRS 12222 Morbidity Mortality Study Group.

J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):555-61. doi: 10.1097/QAI.0b013e3182821821.

30.

Successful integrase inhibitor-based highly active antiretroviral therapy for a multidrug-class-resistant HIV type 1 group O-infected patient in Cameroon.

Aghokeng AF, Kouanfack C, Peeters M, Mpoudi-Ngole E, Delaporte E.

AIDS Res Hum Retroviruses. 2013 Jan;29(1):1-3. doi: 10.1089/AID.2012.0196. Epub 2012 Sep 11. No abstract available.

PMID:
22889147
31.

Noninvasive follow-up of simian immunodeficiency virus infection in wild-living nonhabituated western lowland gorillas in Cameroon.

Etienne L, Locatelli S, Ayouba A, Esteban A, Butel C, Liegeois F, Aghokeng A, Delaporte E, Mpoudi Ngole E, Peeters M.

J Virol. 2012 Sep;86(18):9760-72. doi: 10.1128/JVI.01186-12. Epub 2012 Jun 27.

32.

Ubiquitous Hepatocystis infections, but no evidence of Plasmodium falciparum-like malaria parasites in wild greater spot-nosed monkeys (Cercopithecus nictitans).

Ayouba A, Mouacha F, Learn GH, Mpoudi-Ngole E, Rayner JC, Sharp PM, Hahn BH, Delaporte E, Peeters M.

Int J Parasitol. 2012 Jul;42(8):709-13. doi: 10.1016/j.ijpara.2012.05.004. Epub 2012 Jun 9.

33.

Refined identification of neutralization-resistant HIV-1 CRF02_AG viruses.

Jacob RA, Abrahams F, Tongo M, Schomaker M, Roux P, Mpoudi Ngole E, Burgers WA, Dorfman JR.

J Virol. 2012 Jul;86(14):7699-703. doi: 10.1128/JVI.00804-12. Epub 2012 May 9.

34.

Failure to detect simian immunodeficiency virus infection in a large Cameroonian cohort with high non-human primate exposure.

Djoko CF, Wolfe ND, Aghokeng AF, Lebreton M, Liegeois F, Tamoufe U, Schneider BS, Ortiz N, Mbacham WF, Carr JK, Rimoin AW, Fair JN, Pike BL, Mpoudi-Ngole E, Delaporte E, Burke DS, Peeters M.

Ecohealth. 2012 Mar;9(1):17-23. doi: 10.1007/s10393-012-0751-0. Epub 2012 Mar 7.

PMID:
22395958
35.

Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon.

Kouanfack C, Aghokeng AF, Mondain AM, Bourgeois A, Kenfack A, Mpoudi-Ngolé E, Ducos J, Delaporte E, Laurent C.

Antivir Ther. 2012;17(2):321-6. doi: 10.3851/IMP1911. Epub 2011 Sep 23.

PMID:
22290198
36.

Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.

Aghokeng AF, Kouanfack C, Laurent C, Ebong E, Atem-Tambe A, Butel C, Montavon C, Mpoudi-Ngole E, Delaporte E, Peeters M.

AIDS. 2011 Nov 13;25(17):2183-8. doi: 10.1097/QAD.0b013e32834bbbe9.

PMID:
21860346
37.

Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.

Laurent C, Kouanfack C, Laborde-Balen G, Aghokeng AF, Mbougua JB, Boyer S, Carrieri MP, Mben JM, Dontsop M, Kazé S, Molinari N, Bourgeois A, Mpoudi-Ngolé E, Spire B, Koulla-Shiro S, Delaporte E; Stratall ANRS 12110/ESTHER study group.

Lancet Infect Dis. 2011 Nov;11(11):825-33. doi: 10.1016/S1473-3099(11)70168-2. Epub 2011 Aug 8.

PMID:
21831714
38.

Risk factors for African tick-bite fever in rural central Africa.

Ndip LM, Biswas HH, Nfonsam LE, LeBreton M, Ndip RN, Bissong MA, Mpoudi-Ngole E, Djoko C, Tamoufe U, Prosser AT, Burke DS, Wolfe ND.

Am J Trop Med Hyg. 2011 Apr;84(4):608-13. doi: 10.4269/ajtmh.2011.10-0191.

39.

High failure rate of the ViroSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity.

Aghokeng AF, Mpoudi-Ngole E, Chia JE, Edoul EM, Delaporte E, Peeters M.

J Clin Microbiol. 2011 Apr;49(4):1635-41. doi: 10.1128/JCM.01478-10. Epub 2011 Jan 26.

40.

Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms.

Etienne L, Nerrienet E, LeBreton M, Bibila GT, Foupouapouognigni Y, Rousset D, Nana A, Djoko CF, Tamoufe U, Aghokeng AF, Mpoudi-Ngole E, Delaporte E, Peeters M, Wolfe ND, Ayouba A.

Retrovirology. 2011 Jan 13;8:4. doi: 10.1186/1742-4690-8-4.

41.

High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, Democratic Republic of the Congo.

Djoko CF, Rimoin AW, Vidal N, Tamoufe U, Wolfe ND, Butel C, LeBreton M, Tshala FM, Kayembe PK, Muyembe JJ, Edidi-Basepeo S, Pike BL, Fair JN, Mbacham WF, Saylors KE, Mpoudi-Ngole E, Delaporte E, Grillo M, Peeters M.

AIDS Res Hum Retroviruses. 2011 Mar;27(3):323-9. doi: 10.1089/aid.2010.0201. Epub 2010 Oct 18.

42.

Origin of the human malaria parasite Plasmodium falciparum in gorillas.

Liu W, Li Y, Learn GH, Rudicell RS, Robertson JD, Keele BF, Ndjango JB, Sanz CM, Morgan DB, Locatelli S, Gonder MK, Kranzusch PJ, Walsh PD, Delaporte E, Mpoudi-Ngole E, Georgiev AV, Muller MN, Shaw GM, Peeters M, Sharp PM, Rayner JC, Hahn BH.

Nature. 2010 Sep 23;467(7314):420-5. doi: 10.1038/nature09442.

43.

HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea.

Djoko CF, Wolfe ND, Vidal N, Tamoufe U, Montavon C, LeBreton M, Pike BL, Fair J, Mbacham WF, Benito A, Rimoin AW, Saylors K, Mpoudi-Ngole E, Grillo MP, Peeters M.

AIDS Res Hum Retroviruses. 2010 Sep;26(9):1027-31. doi: 10.1089/aid.2010.0046.

44.

HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: evolutionary relics?

Carr JK, Wolfe ND, Torimiro JN, Tamoufe U, Mpoudi-Ngole E, Eyzaguirre L, Birx DL, McCutchan FE, Burke DS.

Retrovirology. 2010 Apr 28;7:39. doi: 10.1186/1742-4690-7-39.

45.

Genetic diversity of simian lentivirus in wild De Brazza's monkeys (Cercopithecus neglectus) in Equatorial Africa.

Aghokeng AF, Ayouba A, Ahuka S, Liegoies F, Mbala P, Muyembe JJ, Mpoudi-Ngole E, Delaporte E, Peeters M.

J Gen Virol. 2010 Jul;91(Pt 7):1810-6. doi: 10.1099/vir.0.021048-0. Epub 2010 Mar 10.

46.

WHO clinical criteria-based initiation of antiretroviral therapy: lessons from rural district hospitals in Cameroon with regard to 2009 revised WHO recommendations.

Kouanfack C, Laborde-Balen G, Aghokeng AF, Bourgeois A, Dontsop M, Mben JM, Kazé S, Mpoudi-Ngolé E, Koulla-Shiro S, Delaporte E, Laurent C; Stratall ANRS 12110/ESTHER Study Group.

Trop Med Int Health. 2010 May;15(5):580-3. doi: 10.1111/j.1365-3156.2010.02495.x. Epub 2010 Mar 1.

47.

Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.

Mbougua JB, Laurent C, Kouanfack C, Bourgeois A, Ciaffi L, Calmy A, Gwet H, Koulla-Shiro S, Ducos J, Mpoudi-Ngolé E, Molinari N, Delaporte E.

BMC Public Health. 2010 Mar 1;10:105. doi: 10.1186/1471-2458-10-105.

48.

African great apes are natural hosts of multiple related malaria species, including Plasmodium falciparum.

Prugnolle F, Durand P, Neel C, Ollomo B, Ayala FJ, Arnathau C, Etienne L, Mpoudi-Ngole E, Nkoghe D, Leroy E, Delaporte E, Peeters M, Renaud F.

Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1458-63. doi: 10.1073/pnas.0914440107. Epub 2010 Jan 19.

49.

Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas.

Neel C, Etienne L, Li Y, Takehisa J, Rudicell RS, Bass IN, Moudindo J, Mebenga A, Esteban A, Van Heuverswyn F, Liegeois F, Kranzusch PJ, Walsh PD, Sanz CM, Morgan DB, Ndjango JB, Plantier JC, Locatelli S, Gonder MK, Leendertz FH, Boesch C, Todd A, Delaporte E, Mpoudi-Ngole E, Hahn BH, Peeters M.

J Virol. 2010 Feb;84(3):1464-76. doi: 10.1128/JVI.02129-09. Epub 2009 Nov 11.

50.

Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon.

Aghokeng AF, Mpoudi-Ngole E, Dimodi H, Atem-Tambe A, Tongo M, Butel C, Delaporte E, Peeters M.

PLoS One. 2009 Nov 6;4(11):e7702. doi: 10.1371/journal.pone.0007702.

Supplemental Content

Loading ...
Support Center